# Connecticut — State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers

For Connecticut, price increase % trigger is 16% cumulative increase during the preceding two calendar years for drugs that cost $40 or more for a course of treatment; statute is HB 6669, recorded from its source on 2026-08-14.

- **State:** Connecticut
- **Price increase % trigger:** 16% cumulative increase during the preceding two calendar years for drugs that cost $40 or more for a course of treatment _(verified: appears in the quote below)_
- **Statute:** HB 6669 _(verified: appears in the quote below)_

## What the source says

> HB 6669 updates the WAC increases that must be reported from a 20% WAC increase during the immediately preceding calendar year to a 16% cumulative increase during the preceding two calendar years for drugs that cost $40 or more for a course of treatment.

## Source

- https://www.goodwinlaw.com/en/insights/publications/2025/06/alerts-lifesciences-state-drug-transparency-laws

Last verified: 2026-08-14. Review by: 2027-02-10.
Part of [State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers](https://referencesource.org/drug-price-transparency-thresholds/).